baber/WOPTO huggingface dataset:
Patent CA-3096975-A1 (CA)
Title: Trailer
Inventor: FENNELL BRETT GUY
IPC: B60P7/15
Filed: 2018-06-19
Abstract: The disclosure relates to a trailer for hauling tyres. The trailer includes a frame having a front end, a rear end and a pair of parallel elongate chassis rails. The trailer also includes one or more pairs of transverse rails, each pair of transverse rails being adapted to support one or more tyres in an upstanding position thereon. Each pair of transverse rails is longitudinally translatable with respect to the elongate chassis rails between the front and rear ends of the frame. Each transverse rail in the pair is independently longitudinally translatable with respect to the elongate chassis rails so that the spacing of the pair of transverse rails may be varied to suit a tyre diameter. The trailer is also provided with a tyre stillage associated with each pair of transverse rails for supporting one or more upstanding tyres thereagainst.
Patent CA-3101736-A1 (CA)
Title: Traitement du cancer par blocage de l'il-1 induit par l'hote en combinaison avec une radiotherapie
Inventor: SHAKED YUVAL
IPC: A61K38/05
Filed: 2019-05-29
Abstract: L'invention concerne des agents de blocage contre l'activité d'IL-1a, d'IL-1ß, ou d'IL-1R destinés à être utilisés en combinaison avec une radiothérapie pour traiter des patients cancéreux chez lesquels un traitement par radiothérapie induit l'IL-1a, l'IL-1ß ou les deux dans leur circulation.
Patent CA-3104679-A1 (CA)
Inventor: TRACY ALEX
IPC: A61B5/00
Filed: 2019-07-02
Abstract: Systems and methods for performing quantitative histopathology analysis for determining tissue potency are disclosed. According to some embodiments, a method training a tissue classifier is provided. According to the method, training the tissue classifier includes generating feature fingerprints of detected nuclei within slide images in a control library and clustering the slide images based on their corresponding feature fingerprints. According to some embodiments, a method for utilizing the trained tissue classifier is provided. According to the method, the trained tissue classifier determines whether tissue in an unknown slide image corresponds to slide images clustered during the training of the tissue classifier.
Patent CA-3105284-A1 (CA)
Title: Cellular tube for replacement of traditional gas-charged cartridges in suction stabilizers
Inventor: ROGERS JOHN THOMAS
IPC: F04B43/02
Filed: 2019-07-30
Abstract: An annular tube (304) (or other shape) of elastomeric cellular material comprising elastomeric closed cells having gas infused therein is supported by structures protruding from the bottom surface of a suction stabilizer's head (204) and/or by structures within the interior volume of the annular body (200) of the suction stabilizer (104), preferably with spacing between the outer diameter of the annular tube of the cellular material and the inner walls of the suction stabilizer body. The gas-infused closed cell material may thus be employed in new suction stabilizer or pulsation dampener or to retrofit existing suction stabilizers or pulsation dampeners designed for a gas-filled bladder.
Patent CA-3105303-A1 (CA)
Title: Methode permettant d'ameliorer les proprietes suppressives de lymphocytes treg
Inventor: STAUSS HANS
IPC: A61K39/00
Filed: 2019-04-17
Abstract: La présente invention concerne une méthode pour améliorer la capacité de lymphocytes T régulateurs (Treg) à supprimer des réponses immunitaires comprenant l'augmentation de l'expression de FOXP3 dans une population de Treg.
Patent CA-3107643-A1 (CA)
Inventor: TORI SILVANO
IPC: B41J2/155
Filed: 2019-07-18
Abstract: A multi-chip module (MCM) assembly comprising: a graphite substrate comprising a plurality of silicon chips directly attached to the graphite substrate,anda Printed Wiring Board (PWB) attached to the graphite substrate by means of a solvent-resistant adhesive glue and provided with openings surrounding outer profiles of the silicon chips. A printing bar comprising a plurality of the MCM assemblies is also disclosed.
Patent CA-3109428-A1 (CA)
Title: Savonius wind turbine ratios
Inventor: FARB MARK DANIEL
IPC: F03D9/00
Filed: 2019-10-30
Abstract: A Savonius wind turbine has been noted in the past to have the capability to perform more efficiently than other drag-type vertical axis turbines when built according to certain parameters. The previous literature has missed seeing the ratio of the shaft diameter to the available space for wind to pass through in the center as the crucial relationship on which other improvements in this type of turbine can be built. The chord diameter and overlap distance all depend on the size of the central shaft and its ratio to the inner endpoints of the overlapping semicircular blades. The ratios for maximal efficiency are presented here. These efficient ratios also depend for their execution on the turbine rotating at an ideal tip speed ratio.
Patent CA-3111308-A1 (CA)
Title: Return belt tracking idler for conveyor belt system
Inventor: Wolfe Caleb
IPC: B65G39/12
Filed: 2016-02-29
Abstract: ABSTRACT A concave conveyor belt idler system (10) for use on the return run of a conveyor belt system, the idler (10) being configured to maintain alignment of the belt and inherently adjust any misalignment thereof occurring during operation of the system. The concave conveyor belt idler system (10) includes an elongated support member (22) extending transversely of a conveyor belt return run and supporting a plurality of idler roller modules (20) positioned such that the roller modules (20) along the anterior side of the support member (22) define a cave shape for supporting the conveyor belt (12), with the outer lateral edges at a lower elevation than the central portion of the conveyor belt (12). In a conveyor belt system (10) the concave conveyor belt idler of the disclosed technology is positioned between two planate idler systems (14), on the return run, so that the center roller (461) of the concave idler (10) is in or near the plane of the belt (12) as it traverses the planate idler systems (10), with the remaining rollers (46) of the concave idler (10) positioned below this plane. Date Recue/Date Received 2021-03-05
Patent CA-3112417-A1 (CA)
Inventor: EL-TOUFAILI FAISSAL-ALI
IPC: B01F1/00
Filed: 2019-10-17
Abstract: Process of providing polyacrylamides to a site-of-use comprising at least the steps of mixing a polyacrylamide powder at a manufacturing site with an aqueous liquid, thereby obtaining a homogeneous aqueous polyacrylamide concentrate, transporting said concentrate in a transport unit from the manufacturing site to the site-of-use, and removing the homogeneous aqueous concentrate from the transport unit at the site-of-use. Process of treating subterranean, oil and/or gas bearing formations by injecting an aqueous treatment fluid into at least one wellbore, wherein the aqueous treatment fluid is manufactured by mixing at least an aqueous base fluid with said homogeneous aqueous polyacrylamide concentrate at the site-of-use.
Patent CA-3112450-A1 (CA)
Title: Dispositif medical pouvant etre porte et presentant des composants jetables et reutilisables
Inventor: FARINO KEVIN M
IPC: A61B5/364
Filed: 2019-10-10
Abstract: L'invention concerne des modes de réalisation d'un dispositif pouvant être porté. Le présent dispositif pouvant être porté comprend un composant réutilisable et un composant jetable. Le composant jetable comprend un substrat conçu pour se trouver en contact avec le patient comprenant un adhésif sur un côté inférieur, une électrode sur le côté inférieur, un connecteur électrique de composant jetable, et un connecteur mécanique de composant jetable. Le composant réutilisable comprend une pluralité de boîtiers étanches couplés mécaniquement les uns aux autres et mobiles les uns par rapport aux autres, chacun de la pluralité de boîtiers contenant un ou plusieurs des éléments tels qu'un condensateur et un dispositif de commande, un connecteur mécanique de composant réutilisable conçu pour être relié de manière amovible au connecteur mécanique de composant jetable, et un connecteur électrique de composant réutilisable conçu pour être relié de manière amovible au connecteur électrique de composant jetable. Le dispositif peut comprendre un moniteur physiologique cardiopulmonaire ou un défibrillateur externe automatique, parmi d'autres types de dispositifs.
Patent CA-3114140-A1 (CA)
Inventor: O'HERLIHY ALAN
IPC: G06Q10/00
Filed: 2019-11-20
Abstract: A system for process shaping in a retail store environment comprises a video generation and processing component, a data source integration and aggregation component for aggregating and integrate information received from various sources, a process sensing component for generating one or more continuous processes, a process aggregator and weighing component for aggregating the one or more continuous processes into a merged weighted process, a proof of problem and value component for determining one or more process variations, a ripple effect analyser for sending one or more nudging messages to the retail store environment, and a gamified feedback algorithm component for communicating a nudging action corresponding to a nudging message, to one or more entities in the retail store environment.
Patent CA-3115051-A1 (CA)
Title: Zeolite syntheses and directing agents
Inventor: BURTON ALLEN W
IPC: C01B39/48
Filed: 2019-09-03
Abstract: The zeolite UTD-1 may be formed under hydrothermal synthesis conditions using a directing agent that does not include a metal atom therein. Methods for synthesizing the zeolite UTD-1 may comprise: combining at least a silicon atom source and a directing agent having a structure of (I) in an aqueous medium; forming the zeolite in the aqueous medium under hydrothermal synthesis conditions, such that the zeolite has a framework silicate with a cationic portion of the directing agent occluded within pores or channels of the framework silicate; and isolating the zeolite from the aqueous medium. The zeolite has a powder x-ray diffraction pattern with at least the following 20 scattering angles: 6.0 ± 0.12, 7.6 ± 0.1, 14.66 ± 0.15, 19.7 ± 0.15, 21.27 ± 0.15, 22.13 ± 0.15, 22.61 ± 0.15, and 24.42 ± 0.10 for a borosilicate form zeolite, or 6.0 ± 0.12, 7.6 ± 0.15, 14.55 ± 0.15, 19.64 ± 0.15, 21.01 ± 0.20, 21.90 ± 0.20, 22.34 ± 0.20, and 24.38 ± 0.20 for an aluminosilicate form zeolite.
Patent CA-3115195-A1 (CA)
Title: Solutions oromuqueuses de zolpidem ou sels pharmaceutiquement acceptables de celles-ci
Inventor: PATEL NISHEEL K
IPC: A61K9/08
Filed: 2019-10-04
Abstract: La présente invention concerne des formulations buccales ou sublinguales de zolpidem ou un sel pharmaceutiquement acceptable de celles-ci. Les formulations réduisent au minimum la quantité d'amplificateurs de pénétration tout en assurant une pénétration transmucosale rapide du médicament. Ces formulations permettent non seulement une concentration souhaitée (0,5 % à 10 % p/v) du médicament sous la forme d'une solution claire, mais permettent également d'obtenir des formulations stables pendant toute la durée de conservation qui est d'au moins environ 2 ans. Le pH des solutions non aqueuses stables de la présente invention est compris entre 5 et 9, de préférence entre 6 et 9, et de préférence encore entre 7 et 9.
Patent CA-3115899-A1 (CA)
Title: Connexion en ligne de fournisseurs de services
Inventor: NEVO JOSEPH
IPC: G06Q10/06
Filed: 2019-10-02
Abstract: L'invention concerne, selon certains aspects, un procédé mis en uvre par ordinateur consistant à : recevoir des paramètres de demande d'un consommateur de service liés à un service requis ; récupérer au moins un fournisseur de services qui est conforme aux paramètres de demande provenant d'au moins un fournisseur de services ; et établir une connexion entre le consommateur de services et le fournisseur de services par l'intermédiaire d'une session interactive. Selon certains aspects de l'invention, un appareil informatisé comprend un processeur conçu pour exécuter les étapes spécifiées dans le procédé mentionné ci-dessus. Selon certains aspects de l'invention, un produit de programme informatique comprend un support de stockage lisible par ordinateur stockant des instructions de programme, lesdites instructions de programme amenant le processeur à exécuter le procédé mentionné ci-dessus lorsqu'elles sont lues par un processeur. Certains modes de réalisation de l'invention comprennent l'estimation de revenus d'au moins un fournisseur de services sur la base de données enregistrées concernant des transactions. Des paramètres de demande peuvent être reçus par analyse de la parole.
Patent CA-3116294-A1 (CA)
Inventor: CHAE JIN-A
IPC: C12N15/86
Filed: 2019-10-21
Abstract: The present invention relates to an anti-L1CAM antibody specifically binding to L1CAM antigen or an antigen-binding fragment thereof, a chimeric antigen receptor comprising same, and uses thereof. The anti-L1CAM antibody or the antigen-binding fragment of the present invention is excellent in specificity and affinity to L1CAM and thus may be used in the treatment and diagnosis of cancers related to high expression of L1CAM and diseases related to inflammatory disorders. In particular, when the chimeric antigen receptor comprising the anti-L1CAM antibody of the present invention is expressed in effector cells such as T lymphocytes, the chimeric antigen receptor may be effectively used as immunotherapy for cancers related to L1CAM and inflammatory disorders.
Patent CA-3117121-A1 (CA)
Title: Domaine de liaison
Inventor: BULEK ANNA
IPC: A61K47/68
Filed: 2019-10-31
Abstract: La présente invention concerne un variant d'un domaine de liaison à l'antigène qui comprend au moins une mutation dans le domaine VH par comparaison avec un anticorps de référence et qui affiche une affinité accrue pour TRBC2 vis-à-vis de l'anticorps de référence. L'invention concerne en outre un anticorps, un récepteur antigénique chimérique (CAR), et un activateur de lymphocyte T bispécifique (BiTE), une cellule qui comprend ledit CAR, et un conjugué comprenant ledit variant du domaine de liaison à l'antigène ou ledit anticorps. De plus, l'invention concerne des utilisations médicales, des méthodes de diagnostic et des méthodes médicales personnalisées utilisant les produits selon l'invention.
Patent CA-3117621-A1 (CA)
Title: Transportable side-access cargo container with a controllably deployable second floor
Inventor: PROTEAU JOHN
IPC: B60P3/363
Filed: 2021-05-07
Abstract: Disclosed are transportable containers for mounting onto a rearward portion of the frame of a semi-truck comprising. The transportable containers may have a frame comprising: a first wall; a second wall opposing the first wall; two opposed lateral walls extending between the first side and the second side, at least one of the lateral walls comprising an opening formed therein; a top extending over the first wall, the second wall, and the two lateral walls; a second floor contained within an internal space of the frame, the second floor being controllably deployable between a lowered position and a raised position; and a loading ramp hingedly attached to a base of the at least one lateral side having the opening formed therein.
Patent CA-3118179-A1 (CA)
Title: Composition comprenant un sel de choline d'un acide gras et son utilisation en tant que fongicide
Inventor: DE SAEGHER JOHAN
IPC: A01N37/02
Filed: 2019-11-22
Abstract: La présente invention concerne un procédé de lutte contre une infection fongique ou de prévention d'une telle infection fongique sur une plante ou une partie de plante, le procédé comprenant l'application d'une composition comprenant un sel de choline d'un acide gras en C8-C10, tel que le pélargonate de choline, sur la plante, la partie de plante ou le site de croissance de la plante. L'invention concerne également l'utilisation d'une composition comprenant un sel de choline d'un acide gras en C8-C10 en tant que fongicide sur une plante ou une partie de plante.
Patent CA-3118654-A1 (CA)
Title: System and method of automating a slide drilling operation
Inventor: GROOVER AUSTIN
IPC: E21B7/00
Filed: 2018-12-17
Abstract: A system and method of automating a slide drilling operation comprising a plurality of tasks is described. The method includes presenting, on a GUI, selectable indicators, with each indicator being associated with one task from the plurality of tasks; wherein the GUI is coupled to a controller in communication with drilling equipment, wherein the controller is configured to: receive data from the drilling equipment; and control the drilling equipment using predetermined workflows and task parameters; receiving a selection command associated with: a selectable indicator, a first task, and a first predetermined workflow; presenting on the GUI, in response to the receipt of the selection command, a dialogue box for receiving task parameters associated with the first predetermined workflow; receiving, using the dialogue box, the task parameters; and executing, using the controller and the drilling equipment, the first task using the first predetermined workflow and the first plurality of task parameters.
Patent CA-3119223-A1 (CA)
Inventor: KANSAU IMAD
IPC: A61P1/04
Filed: 2019-11-08
Abstract: The present inventors have identified an miRNA capable of greatly modulating the inflammatory response induced by Clostridium difficile. They thus propose incorporating this miRNA into a pharmaceutical composition for preventing or reducing the harmful effects of this infection on the bowels of infected patients. This microRNA is miR-27a-5p. Advantageously, this miRNA can be linked to a matrix, incorporated into particles, or conveyed by a vector. It can be administered to infected subjects for therapeutic purposes.
Patent CA-3119407-A1 (CA)
Title: Process for treating lignocellulosic biomass
Inventor: BOURAS MERIEM
IPC: C12P7/10
Filed: 2019-12-13
Abstract: The invention relates to a process for treating lignocellulosic biomass, involving the following steps in succession: b) a step of pretreating biomass previously put in acidic conditions or at a neutral pH in a pretreatment reactor (3) in order to produce an acidic or neutral pretreated pulp (MA), alternating with b') a step of pretreating biomass previously put in acidic, neutral or basic conditions, with the optional introduction into the pretreatment reactor (3) of a sufficient amount of a basic aqueous solution (EB) to produce a basic pretreated pulp (MB), and then c) a step of enzymatic hydrolysis, in a hydrolysis reactor (16), of a mixture of the acidic or neutral pretreated pulp (MA) from step b) and the basic pretreated pulp (MB) from step b').
Patent CA-3124149-A1 (CA)
Title: Variable guide vane assembly with bushing ring and biasing member
Inventor: O'BRIEN JAMES
IPC: F01D9/02
Filed: 2021-07-07
Abstract: A gas turbine engine has: a first component and a second component defining a respective first gaspath surface and a second gaspath surface of an annular gaspath, the first and second gaspath surfaces axially spaced apart from one another by an annular recess in the first component; a bushing ring disposed within the annular recess and defining stem pockets therein; variable guide vanes pivotable about respective vane axes extending between first and second stems; and a biasing member received within the annular recess and disposed axially between the bushing ring and one of the first component and the second component, the biasing member exerting a force against the bushing ring in an axial direction relative to the central axis and towards the other of the first component and the second component.
Patent CA-3124471-A1 (CA)
Inventor: RHODES DANIEL REED
IPC: G01N33/50
Filed: 2019-12-19
Abstract: L'invention concerne des méthodes de détection et de traitement de cancers sensibles à un inhibiteur de point de contrôle consistant à calculer, à déterminer ou à obtenir une expression de PD-L1, une expression de CD8A et une teneur en tumeurs à partir d'un échantillon cancéreux.
Patent CA-3127391-A1 (CA)
Title: Method for preparing drug-linker mc-mmaf for antibody drug conjugate, and intermediates therein
Inventor: XU ZHE
IPC: A61K47/65
Filed: 2019-06-26
Abstract: A preparation method for and an intermediate of a drug-linker for an antibody drug conjugate MC-MMAF. The reaction activity of the N-terminus is improved, so that the occurrence of a racemic reaction is effectively controlled. The toxin MMAF is not directly used and a fragment peptide having low toxicity is used, so that an operation difficulty in mass production is reduced. No reverse-phase preparation is required so that the operations are simple.
Patent CA-3130164-A1 (CA)
Title: Directed interrupt for multilevel virtualization
Inventor: NERZ BERND
IPC: G06F9/48
Filed: 2020-01-10
Abstract: The invention relates to a method for providing an interrupt signal to a first guest operating system. A bus attachment device receives an interrupt signal from a bus connected module with an interrupt target ID identifying a processor assigned for use by the guest operating system as a target processor for handling the interrupt signal. The bus attachment device checks whether the target processor is scheduled for usage by the guest operating system. If the target processor is not scheduled for usage, the bus attachment device forwards the interrupt signal using broadcasting and updates a forwarding vector entry stored in a memory section assigned to a second guest operating system hosting the first guest operating system. The update is used for indicating to the first operating system that there is a first interrupt signal addressed to the interrupt target ID to be handled.
Patent CA-3132643-A1 (CA)
Inventor: MORRISSEY WILLIAM
IPC: H01R43/18
Filed: 2020-03-26
Abstract: The present disclosure provides protective coverings formed by releasably attaching a mold to a metal structure over a connection, such as an exothermic or brazed connection, and injecting a hardening material into one or more fill ports in the mold. The hardening material hardens to form the protective covering encasing the connection.
Patent CA-3132728-A1 (CA)
Inventor: LOYA CARLOS
IPC: A61K31/575
Filed: 2020-03-04
Abstract: The invention relates to methods of treating the symptoms of perimenopause or menopause using positive allosteric modulators ?-aminobutyric acid type A (GABA-A PAMs) receptor, including 3a-hydroxy-3ß-methoxymethyl-21-(1'-imidazolyl)-5a-pregnan-20-one and salts thereof.
Patent CA-3134080-A1 (CA)
Title: Methodes de therapie antitumorale
Inventor: RACHMILEWITZ MINEI TAMAR
IPC: A61K39/395
Filed: 2020-04-13
Abstract: L'invention concerne des méthodes de traitement de tumeurs chez le patient le nécessitant, comprenant l'administration au patient de l'association d'une dose efficace d'un vecteur comprenant un gène chimérique Fas fonctionnellement lié à un promoteur spécifique des cellules endothéliales et d'une dose efficace d'un inhibiteur de point de contrôle immunitaire. Dans certains aspects de l'invention, l'inhibiteur de point de contrôle immunitaire est un antagoniste de PD-1 ou un antagoniste de PD-L1.
Patent CA-3134420-A1 (CA)
Inventor: JAYNES JESSE
IPC: C07K7/08
Filed: 2020-04-10
Abstract: Aspects of the present disclosure include methods for modulating macrophage activity. Methods according to certain embodiments include contacting a macrophage with a mannose receptor (CD206) binding agent in a manner sufficient to modulate activity of the macrophage. Methods for converting a phenotype of a macrophage from an M2 phenotype to an M1 phenotype are also provided. Methods for inhibiting growth of a CD206-expressing cell as well as methods for treating a subject for a neoplastic condition (e.g., cancer) or a condition associated with chronic inflammation are described. Immuno-modulating peptides suitable for use in the subject methods are also presented.